1. Home
  2. RKLB vs TAK Comparison

RKLB vs TAK Comparison

Compare RKLB & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Lab USA Inc.

RKLB

Rocket Lab USA Inc.

HOLD

Current Price

$90.71

Market Cap

37.7B

Sector

Industrials

ML Signal

HOLD

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

HOLD

Current Price

$16.31

Market Cap

43.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RKLB
TAK
Founded
2006
1781
Country
United States
Japan
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.7B
43.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RKLB
TAK
Price
$90.71
$16.31
Analyst Decision
Buy
Analyst Count
14
0
Target Price
$51.42
N/A
AVG Volume (30 Days)
29.0M
2.6M
Earning Date
02-26-2026
01-29-2026
Dividend Yield
N/A
3.20%
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$554,535,000.00
$29,846,840,032.00
Revenue This Year
$40.29
N/A
Revenue Next Year
$46.77
$0.47
P/E Ratio
N/A
$118.21
Revenue Growth
52.42
N/A
52 Week Low
$14.71
$12.80
52 Week High
$92.19
$16.48

Technical Indicators

Market Signals
Indicator
RKLB
TAK
Relative Strength Index (RSI) N/A 69.60
Support Level N/A $15.87
Resistance Level N/A $16.48
Average True Range (ATR) 0.00 0.19
MACD 0.00 0.03
Stochastic Oscillator 0.00 84.50

Price Performance

Historical Comparison
RKLB
TAK

About RKLB Rocket Lab USA Inc.

Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, and rest of the world and earns key revenue from the United States.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Share on Social Networks: